• Fiscal Year end for Brainstorm Cell Therapeutics Inc falls in the month of December .

    All items in Millions except EPS data.

    12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Sales 0 0 0 0 0
    Cost Of Goods 0 0 0 0 0
    Gross Profit 0 0 0 0 0
    Selling & Adminstrative & Depr. & Amort Expenses 21 25 25 32 23
    Income After Depreciation & Amortization -21 -25 -25 -32 -23
    Non-Operating Income 4 1 0 0 0
    Interest Expense 0 0 0 0 0
    Pretax Income -17 -24 -24 -32 -23
    Income Taxes 0 0 0 0 0
    Minority Interest 0 0 0 0 0
    Investment Gains/Losses 0 0 0 0 0
    Other Income/Charges 0 0 0 0 0
    Income From Cont. Operations -17 -24 -24 -32 -23
    Extras & Discontinued Operations 0 0 0 0 0
    Net Income (GAAP) -17 -24 -24 -32 -23
    Depreciation Footnote 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Income Before Depreciation & Amortization -21 -25 -24 -31 -23
    Depreciation & Amortization (Cash Flow) 0 0 0 0 0
    Income After Depreciation & Amortization -21 -25 -25 -32 -23
    Earnings Per Share Data 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Average Shares 43.08 36.51 36.18 29.85 21.91
    Diluted EPS Before Non-Recurring Items -0.51 -0.66 -0.68 -1.07 -1.06
    Diluted Net EPS (GAAP) -0.40 -0.66 -0.68 -1.07 -1.06

    Fiscal Year end for Brainstorm Cell Therapeutics Inc falls in the month of December .

    All items in Millions except EPS data.

    3/31/24 12/31/23 9/30/23 6/30/23 3/31/23
    Sales NA 0.00 0.00 0.00 0.00
    Cost Of Goods NA 0.00 0.00 0.00 0.00
    Gross Profit NA 0.00 0.00 0.00 0.00
    SG&A, R&D, and Dept/Amort Expenses 0.00 4.81 6.04 5.45 5.15
    Income After SG&A, R&D, and Dept/Amort Expenses 0.00 -4.81 -6.04 -5.45 -5.15
    Non-Operating Income NA -0.77 4.81 0.12 0.09
    Interest Expense NA 0.00 0.00 0.00 0.00
    Pretax Income NA -5.58 -1.23 -5.33 -5.06
    Income Taxes NA 0.00 0.00 0.00 0.00
    Minority Interest NA 0.00 0.00 0.00 0.00
    Investment Gains/Losses NA 0.00 0.00 0.00 0.00
    Other Income/Charges NA 0.00 0.00 0.00 0.00
    Income From Cont. Operations NA -5.58 -1.23 -5.33 -5.06
    Extras & Discontinued Operations NA 0.00 0.00 0.00 0.00
    Income (GAAP) NA -5.58 -1.23 -5.33 -5.06
    Earnings Per Share Data 3/31/24 12/31/23 9/30/23 6/30/23 3/31/23
    Average Shares NA 43.08 44.25 39.70 36.74
    Diluted EPS Before Non-Recurring Items NA -0.11 -0.14 -0.13 -0.14
    Diluted Net EPS (GAAP) NA -0.10 -0.03 -0.13 -0.14